Tvardi Therapeutics (TVRD) EV to CFO (2014 - 2025)
Tvardi Therapeutics' EV to CFO came in at -2.47 for Q1 2025.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) EV to CFO (2014 - 2025) Analysis & Trends
Over the trailing twelve months to Mar 31, 2025, Tvardi Therapeutics reported EV to CFO of -31.69.
- The Q1 2025 figure represents the highest quarterly EV to CFO since Q3 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Tvardi Therapeutics | 12.01 Mn | 12.01 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -2.47 |
| Sep 30, 2021 | 27.14 |
| Jun 30, 2021 | 35.54 |
| Mar 31, 2021 | 100.54 |
| Jun 30, 2018 | 403.91 |
| Mar 31, 2014 | 144.04 |
API Access
Tvardi Therapeutics EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();